New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition.
BOSTON, Dec. 6, 2025 /PRNewswire/ —
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition.
BOSTON, Dec. 6, 2025 /PRNewswire/ —

Scarlets: J Davies; Rogers, James, J Williams, Mee; Costelow, G Davies; Mathias, Elias, Holz, Lousi, Ball, Douglas, Macleod (capt), Anderson.
Replacements: Van der Merwe, S O’Connor, H Thomas, Taylor, Davis, Blacker, Hawkins, J Roberts.
Bristol:…

Bath: De Glanville; Cokanasiga, Ojomoh, Redpath, Arundell; Russell, Spencer; Obano, Dunn, Stuart, Roux, Ewels, Bayliss, Pepper, Reid.
Replacements: Tuipulotu, Van Wyk, Du Toit, Molony, Hill, Carr-Smith, Carreras, Underhill.
Munster: Daly; Kilgallen,…

New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition.
BOSTON, Dec. 6, 2025 /PRNewswire/ — MENU – ORDER AI, the first real-time GLP-1…

Wondering if Jamf Holding at around $12.97 is quietly setting up a value opportunity, or if the market is signaling you should stay cautious? This breakdown is designed to help you decide with confidence.
While the stock is roughly flat over the last week (up 0.3%) and month (up 0.8%), it is still down 7.9% year to date and 15.9% over the past year, with a much steeper slide of 40.1% over three years and 59.8% over five years that has many investors asking whether expectations have finally reset.
Recent headlines around Jamf have focused on how it is positioning itself as a go to platform for managing Apple devices at scale in enterprises and education, alongside ongoing efforts to sharpen its product offering and customer reach. That mix of strategic investment and market skepticism is a big part of why today’s share price looks so different to where it traded a few years ago.
On our framework, Jamf Holding scores a 5 out of 6 valuation score, suggesting the market may be underestimating it across most of our checks. Next, we will unpack what that actually means through multiple valuation lenses, before finishing with a more holistic way to think about value beyond the usual models.
Find out why Jamf Holding’s -15.9% return over the last year is lagging behind its peers.
A Discounted Cash Flow, or DCF, model estimates what a business is worth today by projecting the cash it could generate in the future and then discounting those cash flows back to their value in today’s dollars.
For Jamf Holding, the model starts with last twelve month Free Cash Flow of about $110.1 million and projects how that could grow over time, using analyst estimates for the next few years and then extrapolating further out. On this basis, Jamf’s annual Free Cash Flow is expected to rise to roughly $275.4 million by 2035, which reflects a steady ramp up in cash generation as the business scales.
Using a 2 Stage Free Cash Flow to Equity approach, those projected cash flows translate into an estimated intrinsic value of about $22.81 per share. Compared with the current share price of roughly $12.97, the DCF suggests the stock is trading at a 43.1% discount, indicating potential upside if the cash flow projections are realized.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Jamf Holding is undervalued by 43.1%. Track this in your watchlist or portfolio, or discover 907 more undervalued stocks based on cash flows.
Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Jamf Holding.

The combination of carfilzomib (Kyprolis), lenalidomide (Revlimid), and dexamethasone (KRd) delivered improvements in progression-free survival (PFS) vs bortezomib (Velcade) plus lenalidomide and dexamethasone (VRd) in patients with newly…

Video games have a tendency to be very impatient in a way that I think often makes for a worse experience. Constant rewards of many flavours push us to chase after the next challenge, there’s not nearly enough games that ask us…

Elon Musk attends the U.S.-Saudi Investment Forum in Washington, D.C., U.S., November 19, 2025.
Evelyn Hockstein | Reuters
Elon Musk on Saturday dismissed media reports that SpaceX is raising funds at an $800 billion valuation, calling them inaccurate.
“SpaceX has been cash flow positive for many years and does periodic stock buybacks twice a year to provide liquidity for employees and investors,” Musk said in a post on X.